PROSTAGLANDIN-NITROOXY-DERIVATE

European patent · EP1704141 · Deleted

Register entry

Publication number
EP1704141
Application number
EP04804405
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Dec 27, 2004
Published
Sep 27, 2006
Granted
Feb 24, 2016
Deleted
Dec 27, 2024
Reason
Maximum term reached
IPC classes
C07C 405/00 (2006.01)
A61P 27/06 (2006.01)
A61K 31/5575 (2006.01)
Priority
EP 04100001 05.01.2004
PCT application
PCT/EP2004/014820 27.12.2004
PCT publication
WO2005/068421 28.07.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 27, 2024

    Maximum term reached

    Status of protective title
    Active → Cancelled
    Cancellation date
    27.12.2024
    Cause for cancellation
    Expiry of maximum term of protection

    Published in Swissreg on 27.12.2024

  2. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  3. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  4. Jul 13, 2022

    Change

    Published in Swissreg on 13.07.2022

  5. Oct 27, 2021

    Change

    Published in Swissreg on 27.10.2021

  6. Feb 24, 2016

    Granted

    Published in Swissreg on 24.02.2016

  7. Feb 24, 2016

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 24.02.2016

Parties

Holder

NICOX S.A.

Nicox S.A.

Drakkar 2 - Bât D 2405 route des Dolines - CS 10313 Sophia Antipolis, 06560 Valbonne, FR

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

ONGINI, Ennio

I-20090 Segrate, IT

BENEDINI, Francesca

I-20132 Milano, IT

CHIROLI, Valerio

20113 Milano, IT

DEL SOLDATO, Piero

I-20052 Monza, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.